Search: onr:"swepub:oai:lup.lub.lu.se:470202d1-7e7f-4c35-a077-5b7617347a35" >
TRITON and Beyond: ...
-
Jakubowski, Joseph A
(author)
TRITON and Beyond: New Insights into the Profile of Prasugrel.
- Article/chapterEnglish2012
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:lup.lub.lu.se:470202d1-7e7f-4c35-a077-5b7617347a35
-
https://lup.lub.lu.se/record/2169234URI
-
https://doi.org/10.1111/j.1755-5922.2011.00263.xDOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:art swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
Prasugrel, a third-generation thienopyridine antiplatelet agent, demonstrated superior efficacy to clopidogrel but with an increased risk of bleeding in the phase III pivotal registration Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction (TRITON-TIMI 38). This article reviews and discusses select components of a large literature of prasugrel data that has emerged since the TRITON-TIMI 38 (TRITON) study primary disclosure.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Riesmeyer, Jeffrey S
(author)
-
Close, Sandra L
(author)
-
Leishman, Amy G
(author)
-
Erlinge, DavidLund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)kard-der
(author)
-
KardiologiSektion II
(creator_code:org_t)
Related titles
-
In:Cardiovascular Therapeutics: Wiley30:4, s. 174-1821755-5914
Internet link
Find in a library
To the university's database